Relationship of SH2-B and motility and invasion of colon cancer cells

Chinese Journal of Cancer Prevention and Treatment

Volumn 18, Issue 1, 2011, Pages

  Tang, Fa Qing ^a,b   Li, Jian Guo ^b   Chen, Yu ^b   Wang, Wei Wei ^b   Wu, Yuan ^b   Duan, Chao Jun ^b  

^a JINAN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adaptor proteins; Colonic neoplasms; Neoplasms metastasis; Protein tyrosine kinase

Indexed keywords

PROTEIN SH2; PROTEIN SH2 B; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER INVASION; CELL COUNT; CELL INVASION; CELL MOTILITY; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; DNA TRANSFECTION; DNA VECTOR; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; METASTASIS; PROTEIN EXPRESSION; WOUND HEALING;

EID: 80051954560     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Labianca R, Beretta G D, Kildani B, et al. Colon cancer[J]. Crit Rev Oncol Hematol, 2010,74(2):106-133.
2. Engholm G, Gislum M, Bray F, et al. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods[J]. Acta Oncol, 2010,49(5):545-560.
3. Gallagher D J, Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure[J]. Oncology, 2010,78(3-4):237-248.
4. Ren D, Li M, Duan C, et al. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice[J]. Cell Metab, 2005,2(2):95-104.
5. Duan C, Li M, Rui L. SH2-B promotes insulin receptor substrate 1 (IRS1)-and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin[J]. J Biol Chem, 2004,279(42):43684-43691. (Pubitemid 39390672)
6. Li Z, Zhou Y, Carter-Su C, et al. SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms[J]. Mol Endocrinol, 2007,21(9):2270-2281. (Pubitemid 47347387)
7. Young M A, Gonfloni S, Superti-Furga G, et al. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation[J]. Cell, 2001,105(1):115-126. (Pubitemid 32323921)
8. Chen J, Huang X F. The signal pathways in azoxymethane-induced colon cancer and preventive implications[J]. Cancer Biol Ther, 2009,8(14):1313-1317.
9. Diakonova M, Gunter D R, Herrington J. SH2-B- Is a Rac-binding protein that regulates cell motility[J]. The Journal of Biological Chemistry, 2002,277(12):10669-10677. (Pubitemid 34968194)
10. Li Z, Zhou Y, Carter-Su C, et al. SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms[J]. Mol Endocrinol, 2007,21(9):2270-2281. (Pubitemid 47347387)
11. Yoshiga D, Sato N, Torisu T, at al. Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma messenger ribonucleic acid levels[J]. Mol Endocrinol, 2007,21(5):1120-1131.
12. Zhou S Y, Cantley L C. ZIP codes for delivering SH2 domains[J]. Cell, 2004,116(2 Suppl):41-43.
13. Chen L, Carter-Su C. Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation[J]. Mol Cell Biol, 2004,24(9):3633-3647.
14. Schramm A, Schulte J H, Astrahantseff K. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma[J]. Cancer Lett, 2005,228(1-2):143-153. (Pubitemid 41188436)
15. Darnell J E Jr. STATs and gene, regulation[J]. Science, 1997,277(5332):1630-1635.
16. Rger J D. SH2 Domain-containing signaling proteins in human breast cancer[J]. Breast Can Res Treat, 1995,34(1):85-92.
17. Lazer G, Pe'er L, Farago M, et al. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity[J]. J Biol Chem, 2010,285(30):23075-23085.
18. Yousaf M N. Model substrates for studies of cell mobility[J]. Curr Opin Chem Biol, 2009,13(5-6):697-704.